Biowerkli
Smart CGT
Biomanufacturing and
Analytics with
Swiss Audit Ready
AI Platform
Get connected
Who we are:
Swiss based dynamic team backed up by world class open source AI and biotechnology
  • Our Mission
    To empower the global biotech and advanced therapy community with transparent, accessible AI and smart biomanufacturing tools, accelerating the development, manufacturing, and release of safe, life-changing therapies for patients everywhere.
  • Our Vision
    A future where intelligent, open, and collaborative biomanufacturing makes advanced therapies universally accessible - reaching every patient who needs them, without barriers.
Problem Statement
Manufacturing and Analytics Data are Fragmented, Blocking Fast Insight into Success vs Failure
  • Troubleshooting
    Troubleshooting relies on incomplete datasets and manual expert interpretation.
  • Production and QC data
    Production and QC data are typically siloed across sites, systems, and formats,
    inconsistent and hard to connect.
  • Decisions speed
    Decisions are slowed by data gaps, delays, and subjective judgment.
  • Existing AI tools
    Existing AI tools are hard to deploy due to integration complexity, shifting priorities, and
    data security concerns.
  • Untapped insights
    Untapped insights remain locked away: preventing systematic increases in batch success
    rates. slowing yield optimization, delaying batches, and increasing cost of goods.
  • The Result
    Recurring issues, costly delays, and avoidable batch failures.
BioWerkli Solution
Smart biomanufacturing and release with purpose built Swiss AI platform
Inspired by Apertus, Switzerland’s open, transparent, Large Language Model, developed with
the highest standards of ethics, data governance, and scientific rigor.

Jointly advanced by
three leading world institutions.


How it works
We turn disconnected data into a predictive engine for manufacturing and release success
Input:

Donor/patient material • Material type (apheresis, bone marrow, biopsy, etc.) • Collection centre, time from collection to processing • Cell count (TNC, CD3+, CD34+, etc.) • , etc.

Output:

What If / Post Mortem Analyses

Impact of Insights if we had today’s learnings yesterday

Rewriting the outcome

Predictive analytics

“Working in bio-manufacturing? Join the waitlist - we’ll notify you as we expand our early-access program.”
Be the first to know
Follow us on LinkedIn
Made on
Tilda